Company intelligence / Profile preview

Akumentis Healthcare

Thane, Maharashtra, Indiaakumentishealthcare.com ↗

Ownership: Private
Employees: ~758
Development stage: Other

Overview

Akumentis Healthcare develops and markets over a hundred innovative products across at least eight major therapeutic segments. It has recently launched a cannabis plant-based anti-seizure medication ("Clasepi") for rare pediatric epilepsies after clinical trials on over two hundred patients. The company holds a strong position in women’s health but also covers pain/inflammation management, osteoporosis care, pediatrics/geriatrics nutrition among others. Its manufacturing units are certified by WHO-GMP/ISO/USFDA/UKMHRA standards.

Therapeutic areas: Metabolic DisordersNeurologyInfectious DiseasesOphthalmologyGastroenterologyEndocrinologyOtherRheumatologyWomen's Health
Modalities: Small moleculePlant-derived medicineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Akumentis Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akumentis Healthcare.

Explore the full profile